Why were Trump’s tariffs reinstated by appeals court?
How did Nvidia’s earnings impact chip stocks today?
What caused the US Court to block Trump’s tariffs?
Why is UnitedHealth Group’s CEO pay package controversial?
How are US-China trade talks affecting global markets?
Why is Victoria’s Secret website down due to security?
How is AI adoption affecting tech company hiring?
Intellia Therapeutics' Rare Heart Disease Candidate Reports Liver Enzyme Spike In Phase 3 Trial, But Stays On Course
benzinga.com/25/05/45674452/intellia-therapeutics-rare-heart-disease-candidate-reports-liver-enzyme-spike-in-phase-3-trial-but-stays-on-cours
Intellia Therapeutics Inc (NASDAQ: NTLA) said on Wednesday that a single, recent, asymptomatic patient has had grade 4 (severe) liver transaminase elevations (liver enzymes) based on laboratory tests in its Phase 3 MAGNITUDE study.
The trial is evaluating nexiguran ziclumeran (nex-z,…
This story appeared on benzinga.com, 2025-05-29 15:25:36.